{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T05:13:29Z","timestamp":1789017209449,"version":"build-2803163510"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,1,7]],"date-time":"2022-01-07T00:00:00Z","timestamp":1641513600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,1,7]],"date-time":"2022-01-07T00:00:00Z","timestamp":1641513600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arthritis Res Ther"],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Although the risk of cardiovascular disease has been discussed extensively in both psoriasis (PsO) and psoriatic arthritis (PsA), very few studies have addressed the occurrence of venous thromboembolic (VTE) events among PsO patients, and even fewer in PsA. Thus, our goal was to assess the association between PsA and VTE events using a large population-based database.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>This retrospective cohort study includes all 5,275 patients with newly diagnosed PsA from the largest health care provider in Israel between January 2003 and December 2018. Identified PsA patients were matched by age, sex, ethnicity, and index date with 21,011 controls without PsA from the same database. Both groups were followed through June 30, 2019 for the occurrence of VTE event. Cox proportional hazard regression models were used to assess the association between PsA and VTE.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>PsA cohort consisted of 53.2% females with mean age of 51.7\u00b115.4 Sixty-two patients (1.2%) were diagnosed with VTE in the PsA group and 176 patients (0.8%) in the control group (p=0.023, HR=1.40, 95% CI 1.05-1.87). However, there was no increased risk of VTE among PsA patients on multivariable analysis (p=0.16, HR=1.27, 95% CI 0.91-1.80). Within the PsA group, patients with VTE were more often of older age and with history of VTE.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>This study suggests that the increased risk of VTE in PsA patients appears to be related to the underlying comorbidities and not independently associated with PsA. Age and previous history of VTE were the only risk factors associated with increased risk of VTE in patients with PsA. Addressing VTE risk is recommended especially in the era of Janus kinase inhibitors.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13075-021-02703-8","type":"journal-article","created":{"date-parts":[[2022,1,7]],"date-time":"2022-01-07T09:03:16Z","timestamp":1641546196000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["The association between psoriatic arthritis and venous thromboembolism: a population-based cohort study"],"prefix":"10.1186","volume":"24","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8612-2698","authenticated-orcid":false,"given":"Tal","family":"Gazitt","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacob","family":"Pesachov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Idit","family":"Lavi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muna","family":"Elias","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amir","family":"Haddad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilan","family":"Feldhamer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arnon Dov","family":"Cohen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Walid","family":"Saliba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0523-2292","authenticated-orcid":false,"given":"Devy","family":"Zisman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,1,7]]},"reference":[{"issue":"8","key":"2703_CR1","doi-asserted-by":"publisher","first-page":"2069","DOI":"10.1007\/s10067-019-04528-y","volume":"38","author":"A Kibari","year":"2019","unstructured":"Kibari A, Cohen AD, Gazitt T, Bitterman H, Lavi I, Feldhamer I, et al. Cardiac and cardiovascular morbidities in patients with psoriatic arthritis: a population-based case control study. Clin Rheumatol. 2019;38(8):2069\u201375.","journal-title":"Clin Rheumatol"},{"issue":"2","key":"2703_CR2","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1136\/annrheumdis-2011-201194","volume":"72","author":"A Jamnitski","year":"2013","unstructured":"Jamnitski A, Symmons D, Peters MJL, Sattar N, McInnes I, Nurmohamed MT. Cardiovascular comorbidities in patients with psoriatic arthritis: a systematic review. Ann Rheum Dis. 2013;72(2):211\u20136.","journal-title":"Ann Rheum Dis"},{"issue":"3","key":"2703_CR3","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1007\/s00296-010-1673-1","volume":"32","author":"D Zisman","year":"2012","unstructured":"Zisman D, Eder L, Elias M, Laor A, Bitterman H, Rozenbaum M, et al. Clinical and demographic characteristics of patients with psoriatic arthritis in northern Israel. Rheumatol Int. 2012;32(3):595\u2013600.","journal-title":"Rheumatol Int"},{"key":"2703_CR4","volume-title":"Harrison\u2019s Principles of Internal Medicine, Twentieth Edition (Vol.1 & Vol.2)","author":"J Larry Jameson","year":"2018","unstructured":"Larry Jameson J, Fauci A, Kasper D, Hauser S, Longo D, Loscalzo J. Harrison\u2019s Principles of Internal Medicine, Twentieth Edition (Vol.1 & Vol.2). 20th ed. New York: McGraw-Hill Education \/ Medical; 2018.","edition":"20"},{"issue":"3","key":"2703_CR5","doi-asserted-by":"publisher","first-page":"e18125","DOI":"10.1371\/journal.pone.0018125","volume":"6","author":"O Ahlehoff","year":"2011","unstructured":"Ahlehoff O, Gislason GH, Lindhardsen J, Charlot MG, J\u00f8rgensen CH, Olesen JB, et al. Psoriasis carries an increased risk of venous thromboembolism: a Danish nationwide cohort study. PLoS One. 2011;6(3):e18125.","journal-title":"PLoS One"},{"issue":"10","key":"2703_CR6","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1093\/qjmed\/hcu073","volume":"107","author":"P Ungprasert","year":"2014","unstructured":"Ungprasert P, Sanguankeo A, Upala S, Suksaranjit P. Psoriasis and risk of venous thromboembolism: a systematic review and meta-analysis. QJM. 2014;107(10):793\u20137.","journal-title":"QJM"},{"issue":"11","key":"2703_CR7","doi-asserted-by":"publisher","first-page":"1400","DOI":"10.1136\/annrheumdis-2019-216761","volume":"79","author":"P Mease","year":"2020","unstructured":"Mease P, Charles-Schoeman C, Cohen S, Fallon L, Woolcott J, Yun H, et al. Incidence of venous and arterial thromboembolic events reported in the tofacitinib rheumatoid arthritis, psoriasis and psoriatic arthritis development programmes and from real-world data. Ann Rheum Dis. 2020;79(11):1400\u201313.","journal-title":"Ann Rheum Dis"},{"issue":"6","key":"2703_CR8","first-page":"404","volume":"3","author":"G Rennert","year":"2001","unstructured":"Rennert G, Peterburg Y. Prevalence of selected chronic diseases in Israel. Isr Med Assoc J. 2001;3(6):404\u20138.","journal-title":"Isr Med Assoc J"},{"issue":"1","key":"2703_CR9","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/s13075-017-1497-4","volume":"20","author":"L Eder","year":"2018","unstructured":"Eder L, Cohen AD, Feldhamer I, Greenberg-Dotan S, Batat E, Zisman D. The epidemiology of psoriatic arthritis in Israel - a population-based study. Arthritis Res Ther. 2018;20(1):3.","journal-title":"Arthritis Res Ther"},{"key":"2703_CR10","doi-asserted-by":"crossref","unstructured":"Haddad A, Saliba W, Lavi I, Batheesh A, Kasem S, Gazitt T, Feldhamer I, Cohen A, Zisman D. The association of psoriatic arthritis with all-cause mortality and leading causes of death in psoriatic arthritis. J Rheumatol. 2021. Published on-line ahead of print.","DOI":"10.3899\/jrheum.210159"},{"issue":"7497","key":"2703_CR11","doi-asserted-by":"publisher","first-page":"960","DOI":"10.1136\/bmj.330.7497.960","volume":"330","author":"M Mamdani","year":"2005","unstructured":"Mamdani M, Sykora K, Li P, Normand S-LT, Streiner DL, Austin PC, et al. Reader\u2019s guide to critical appraisal of cohort studies: 2. Assessing potential for confounding. BMJ. 2005;330(7497):960\u20132.","journal-title":"BMJ"},{"issue":"39","key":"2703_CR12","doi-asserted-by":"publisher","first-page":"3608","DOI":"10.1093\/eurheartj\/ehx145","volume":"39","author":"A Ogdie","year":"2018","unstructured":"Ogdie A, Kay McGill N, Shin DB, Takeshita J, Jon Love T, Noe MH, et al. Risk of venous thromboembolism in patients with psoriatic arthritis, psoriasis and rheumatoid arthritis: a general population-based cohort study. Eur Heart J. 2018;39(39):3608\u201314.","journal-title":"Eur Heart J"},{"issue":"1","key":"2703_CR13","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1186\/s13075-017-1315-z","volume":"19","author":"K Bengtsson","year":"2017","unstructured":"Bengtsson K, Forsblad-d\u2019Elia H, Lie E, Klingberg E, Dehlin M, Exarchou S, et al. Are ankylosing spondylitis, psoriatic arthritis and undifferentiated spondyloarthritis associated with an increased risk of cardiovascular events? A prospective nationwide population-based cohort study. Arthritis Res Ther. 2017;19(1):102.","journal-title":"Arthritis Res Ther"},{"issue":"3","key":"2703_CR14","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1016\/j.semarthrit.2021.04.008","volume":"51","author":"AC Damian","year":"2021","unstructured":"Damian AC, Colaco K, Rohekar S, Boyd T, Chandran V, Gladman DD, et al. The incidence and risk factors for venous thromboembolic events in patients with psoriasis and psoriatic arthritis. Semin Arthritis Rheum. 2021;51(3):547\u201352.","journal-title":"Semin Arthritis Rheum"},{"issue":"2","key":"2703_CR15","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1001\/jamacardio.2018.4537","volume":"4","author":"J Gregson","year":"2019","unstructured":"Gregson J, Kaptoge S, Bolton T, Pennells L, Willeit P, Burgess S, et al. Cardiovascular risk factors associated with venous thromboembolism. JAMA Cardiol. 2019;4(2):163\u201373.","journal-title":"JAMA Cardiol"},{"issue":"2","key":"2703_CR16","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1055\/s-0038-1642037","volume":"35","author":"MD Rybstein","year":"2018","unstructured":"Rybstein MD, DeSancho MT. Hypercoagulable states and thrombophilias: risks relating to recurrent venous thromboembolism. Semin Intervent Radiol. 2018;35(2):99\u2013104.","journal-title":"Semin Intervent Radiol"},{"issue":"16","key":"2703_CR17","doi-asserted-by":"publisher","first-page":"1886","DOI":"10.1001\/archinte.159.16.1886","volume":"159","author":"PO Hansson","year":"1999","unstructured":"Hansson PO, Eriksson H, Welin L, Sv\u00e4rdsudd K, Wilhelmsen L. Smoking and abdominal obesity: risk factors for venous thromboembolism among middle-aged men: \u201cthe study of men born in 1913\u201d. Arch Intern Med. 1999;159(16):1886\u201390.","journal-title":"Arch Intern Med"},{"issue":"1","key":"2703_CR18","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/s11239-015-1311-6","volume":"41","author":"JA Heit","year":"2016","unstructured":"Heit JA, Spencer FA, White RH. The epidemiology of venous thromboembolism. J Thromb Thrombolysis. 2016;41(1):3\u201314.","journal-title":"J Thromb Thrombolysis"},{"issue":"2","key":"2703_CR19","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1002\/acr.20363","volume":"63","author":"CC Mok","year":"2011","unstructured":"Mok CC, Ko GTC, Ho LY, Yu KL, Chan PT, To CH. Prevalence of atherosclerotic risk factors and the metabolic syndrome in patients with chronic inflammatory arthritis. Arthritis Care Res (Hoboken). 2011;63(2):195\u2013202.","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"2703_CR20","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1741-7015-9-1","volume":"9","author":"SV Ramagopalan","year":"2011","unstructured":"Ramagopalan SV, Wotton CJ, Handel AE, Yeates D, Goldacre MJ. Risk of venous thromboembolism in people admitted to hospital with selected immune-mediated diseases: record-linkage study. BMC Med. 2011;9:1.","journal-title":"BMC Med"},{"issue":"11","key":"2703_CR21","doi-asserted-by":"publisher","first-page":"1478","DOI":"10.2174\/138161212799504731","volume":"18","author":"K Aksu","year":"2012","unstructured":"Aksu K, Donmez A, Keser G. Inflammation-induced thrombosis: mechanisms, disease associations and management. Curr Pharm Des. 2012;18(11):1478\u201393.","journal-title":"Curr Pharm Des"},{"issue":"5","key":"2703_CR22","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1136\/annrheumdis-2014-206824","volume":"75","author":"AM Gulati","year":"2016","unstructured":"Gulati AM, Semb AG, Rollefstad S, Romundstad PR, Kavanaugh A, Gulati S, et al. On the HUNT for cardiovascular risk factors and disease in patients with psoriatic arthritis: population-based data from the Nord-Tr\u00f8ndelag Health Study. Ann Rheum Dis. 2016;75(5):819\u201324.","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"2703_CR23","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1093\/rheumatology\/kes242","volume":"52","author":"A Russolillo","year":"2013","unstructured":"Russolillo A, Iervolino S, Peluso R, Lupoli R, Di Minno A, Pappone N, et al. Obesity and psoriatic arthritis: from pathogenesis to clinical outcome and management. Rheumatology (Oxford). 2013;52(1):62\u20137.","journal-title":"Rheumatology (Oxford)"},{"issue":"10","key":"2703_CR24","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1007\/s11926-015-0540-1","volume":"17","author":"A Ogdie","year":"2015","unstructured":"Ogdie A, Gelfand JM. Clinical Risk Factors for the Development of Psoriatic Arthritis Among Patients with Psoriasis: A Review of Available Evidence. Curr Rheumatol Rep. 2015;17(10):64.","journal-title":"Curr Rheumatol Rep"},{"issue":"1","key":"2703_CR25","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1007\/s00296-016-3487-2","volume":"37","author":"KM Yim","year":"2017","unstructured":"Yim KM, Armstrong AW. Updates on cardiovascular comorbidities associated with psoriatic diseases: epidemiology and mechanisms. Rheumatol Int. 2017;37(1):97\u2013105.","journal-title":"Rheumatol Int."},{"issue":"4","key":"2703_CR26","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1007\/s11926-012-0260-8","volume":"14","author":"W-H Boehncke","year":"2012","unstructured":"Boehncke W-H, Boehncke S. Cardiovascular mortality in psoriasis and psoriatic arthritis: epidemiology, pathomechanisms, therapeutic implications, and perspectives. Curr Rheumatol Rep. 2012;14(4):343\u20138.","journal-title":"Curr Rheumatol Rep"},{"issue":"3","key":"2703_CR27","doi-asserted-by":"publisher","first-page":"148","DOI":"10.4081\/reumatismo.2011.148","volume":"63","author":"F Atzeni","year":"2011","unstructured":"Atzeni F, Turiel M, Boccassini L, Sitia S, Tomasoni L, Battellino M, et al. Cardiovascular involvement in psoriatic arthritis. Reumatismo. 2011;63(3):148\u201354.","journal-title":"Reumatismo"},{"issue":"5","key":"2703_CR28","first-page":"877","volume":"35","author":"L Eder","year":"2008","unstructured":"Eder L, Zisman D, Barzilai M, Laor A, Rahat M, Rozenbaum M, et al. Subclinical atherosclerosis in psoriatic arthritis: a case-control study. J Rheumatol. 2008;35(5):877\u201382.","journal-title":"J Rheumatol"},{"issue":"2","key":"2703_CR29","doi-asserted-by":"publisher","first-page":"334","DOI":"10.3899\/jrheum.110741","volume":"39","author":"MND Di Minno","year":"2012","unstructured":"Di Minno MND, Iervolino S, Peluso R, Scarpa R, Di Minno G. Platelet reactivity and disease activity in subjects with psoriatic arthritis. J Rheumatol. 2012;39(2):334\u20136.","journal-title":"J Rheumatol"},{"key":"2703_CR30","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/j.cca.2015.04.023","volume":"446","author":"L Chandrashekar","year":"2015","unstructured":"Chandrashekar L, Rajappa M, Revathy G, Sundar I, Munisamy M, Ananthanarayanan PH, et al. Is enhanced platelet activation the missing link leading to increased cardiovascular risk in psoriasis? Clin Chim Acta. 2015;446:181\u20135.","journal-title":"Clin Chim Acta"},{"issue":"11","key":"2703_CR31","doi-asserted-by":"publisher","first-page":"667","DOI":"10.4330\/wjc.v8.i11.667","volume":"8","author":"E Papadavid","year":"2016","unstructured":"Papadavid E, Diamanti K, Spathis A, Varoudi M, Andreadou I, Gravanis K, et al. Increased levels of circulating platelet-derived microparticles in psoriasis: Possible implications for the associated cardiovascular risk. World J Cardiol. 2016;8(11):667\u201375.","journal-title":"World J Cardiol"}],"container-title":["Arthritis Research &amp; Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13075-021-02703-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13075-021-02703-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13075-021-02703-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,7]],"date-time":"2022-01-07T09:09:44Z","timestamp":1641546584000},"score":1,"resource":{"primary":{"URL":"https:\/\/arthritis-research.biomedcentral.com\/articles\/10.1186\/s13075-021-02703-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,7]]},"references-count":31,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["2703"],"URL":"https:\/\/doi.org\/10.1186\/s13075-021-02703-8","relation":{},"ISSN":["1478-6362"],"issn-type":[{"value":"1478-6362","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,1,7]]},"assertion":[{"value":"24 August 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 December 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 January 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by the Institutional Review Board of Carmel Medical Center (CMC-0014-14). Requirement for individual patient consent forms was waived due to the retrospective, observational nature of the study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All authors reviewed the manuscript, helped in editing it, and approved of its publication.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"16"}}